多参数流式细胞术可重复检测急性髓系白血病可测量残留病
研究在246例完成诱导化疗的AML患者中实施八色流式panel,采用固定门控的分层设门策略建立基于LAIP的DfN方法,监测32个异常亚群,并以90例无白血病对照建立参考值。73%患者达细胞形态学缓解,缓解者中MRD阳性总生存更短(HR 3.8,p=0.006),MRD阴性未缓解者与MRD阴性缓解者总生存相当,MRD检测评分者间信度高(Krippendorff α=0.860)。
要点
- 八色单管流式配合固定门控分层设门,可标准化检测AML的MRD。
- 缓解患者中MRD阳性者总生存更短(HR 3.8,p=0.006)。
- MRD检测评分者间信度高(Krippendorff α=0.860),平均分析耗时04:31分钟。
核心结论
- 该单管多参数流式方法检测MRD标准化程度高,评分者间信度有前景且周转快。
- 该策略定义的MRD提供相关预后信息,并确立不成熟标志物细胞群之外的异常为独立风险特征。
- 作者认为该策略可能为多中心免疫表型MRD评估提供基础。
研究设计与样本
- 研究纳入246例完成诱导化疗的AML患者,监测32个伴或不伴不成熟标志物表达的异常表型亚群。
- 采用八色panel和固定门控的分层设门策略,建立基于LAIP的DfN方法。
- 以90例无白血病对照建立参考值。
主要发现
- 73%患者经细胞形态学达缓解。
- 缓解者中MRD阳性患者总生存更短(HR 3.8,p=0.006)。
- MRD阴性未缓解者总生存与MRD阴性缓解者相当。
- MRD检测评分者间信度高,Krippendorff α为0.860。
- 随访时MRD分析平均耗时04:31分钟。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Measurable residual disease (MRD) detected by multiparametric flow cytometry (MFC) is associated with unfavorable outcome in patients with AML. A simple, broadly applicable eight-color panel was implemented and analyzed utilizing a hierarchical gating strategy with fixed gates to develop a clear-cut LAIP-based DfN approach. In total, 32 subpopulations with aberrant phenotypes with/without expression of markers of immaturity were monitored in 246 AML patients after completion of induction chemotherapy. Reference values were established utilizing 90 leukemia-free controls. Overall, 73% of patients achieved a response by cytomorphology. In responders, the overall survival was shorter for MRDpos patients (HR 3.8, p = 0.006). Overall survival of MRDneg non-responders was comparable to MRDneg responders. The inter-rater-reliability for MRD detection was high with a Krippendorffs α of 0.860. The mean time requirement for MRD analyses at follow-up was very short with 04:31 minutes. The proposed one-tube MFC approach for detection of MRD allows a high level of standardization leading to a promising inter-observer-reliability with a fast turnover. MRD defined by this strategy provides relevant prognostic information and establishes aberrancies outside of cell populations with markers of immaturity as an independent risk feature. Our results imply that this strategy may provide the base for multicentric immunophenotypic MRD assessment.
引用
- Röhnert MA, Kramer M, Schadt J, et al. Reproducible measurable residual disease detection by multiparametric flow cytometry in acute myeloid leukemia. Leukemia. 2022. PMID: 35851154. doi:10.1038/s41375-022-01647-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。